Michael Zelefsky
NYU Langone Health · Memorial Sloan Kettering Cancer Center · Memorial Sloan Kettering Cancer Centre
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Michael Zelefsky as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 09:39 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT07801664 · Short Course ADT for High Risk Low/Intermediate Risk ARTERA Prostate CancerNYU Langone Health · recruiting · Prostate Cancer · principal investigator
- N/ANCT07142967 · Trial Evaluating the Safety and Efficacy Of MR-Linac-Guided Radiotherapy as Salvage Treatment After External Beam Radiotherapy Recurrence (TUMORNATOR II)NYU Langone Health · recruiting · Intraprostatic Prostate Cancer · principal investigator
- N/ANCT06542757 · Evaluation of Tumor Control Based on Serial Multiparametric MRI and Post-Treatment Biopsies For Patients Treated With Dose Intensification to the Dominant Intra-Prostatic Lesion (DIL) Using Ultra-Hypofractionated, MR-Guided RadiotherapyNYU Langone Health · recruiting · Prostate Cancer · principal investigator
- Ph2NCT06397703 · ADT and SBRT vs SBRT Alone for Unfavorable Intermediate Risk Prostate CancerNYU Langone Health · recruiting · Prostate Cancer · principal investigator
- Ph3NCT03056638 · Trial of ADT and SBRT Versus SBRT for Intermediate Prostate CancerMemorial Sloan Kettering Cancer Center · terminated · Prostate Cancer · principal investigator
- Ph2NCT02353832 · Stereotactic Ablative Radiotherapy (SABR) for Low Risk Prostate Cancer With Injectable Rectal SpacerUniversity of Texas Southwestern Medical Center · completed · Prostate Cancer · principal investigator
- Ph2NCT01354951 · Assessing the Potential for Reduced Toxicity Using Focal Brachytherapy in Early Stage, Low Volume Prostate CancerMemorial Sloan Kettering Cancer Center · terminated · Prostate Cancer · principal investigator
- Ph1NCT00678158 · Study Using High-Dose Single Fraction Image-Guided Radiotherapy for Metastatic Lesions to Soft Tissue Masses, Lymph Node, or BoneMemorial Sloan Kettering Cancer Center · completed · Metastatic Disease · principal investigator
- N/ANCT00582959 · Feasibility Study of Cone Beam Imaging for Radiation Therapy Treatment VerificationMemorial Sloan Kettering Cancer Center · completed · Radiation Treatment for Tumors · principal investigator
- N/ANCT00132704 · An Analysis of the Response of Human Tumor Microvascular Endothelium to Ionizing RadiationMemorial Sloan Kettering Cancer Center · completed · Ovarian Neoplasms, Colorectal Neoplasms, Melanoma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 09:39 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 09:39 UTC. The ranking covers the 200 most relevant of 57 PubMed records, and a shared surname and initials can bring in a namesake. All 57 on PubMed
- Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer.Int J Radiat Oncol Biol Phys · 1998769 citationsRCR 25.5
- Clinical experience with intensity modulated radiation therapy (IMRT) in prostate cancer.Radiother Oncol · 2000402 citationsRCR 12.8
- 266 citationsRCR 8.6
- 249 citationsRCR 6.2
- 242 citationsRCR 8.3
- Ultra-high dose (86.4 Gy) IMRT for localized prostate cancer: toxicity and biochemical outcomes.Int J Radiat Oncol Biol Phys · 2008212 citationsRCR 6.3
- Salvage re-irradiation for recurrent head and neck cancer.Int J Radiat Oncol Biol Phys · 2007206 citationsRCR 5.7
- Detailed quality of life assessment in patients treated with primary radiotherapy for squamous cell cancer of the base of the tongue.Head Neck · 1997173 citationsRCR 7.9
- Predictors of biochemical outcome with salvage conformal radiotherapy after radical prostatectomy for prostate cancer.J Clin Oncol · 2003167 citationsRCR 3.8
- Tumor control outcomes after hypofractionated and single-dose stereotactic image-guided intensity-modulated radiotherapy for extracranial metastases from renal cell carcinoma.Int J Radiat Oncol Biol Phys · 2012160 citationsRCR 4.5